June 2007. Volume 3. Number 2

Palivizumab prophylaxis against respiratory syncytial virus

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AT | Translated Articles

Translator: Aizpurua Galdeano P1.
1ABS 7 La Salut Badalona. Badalona. España.
Correspondence: Pilar Aizpurua Galdeano. Email: 19353pag@gmail.com
Publication date: 01/01/2007

AT | Translated Articles

Translator: Aizpurua Galdeano P1.
1ABS 7 La Salut Badalona. Badalona. España.
Correspondence: Pilar Aizpurua Galdeano. Email: 19353pag@gmail.com
Publication date: 01/01/2007

Article Origin

University of York. Centre for Reviews and Dissemination (CRD). Health Technology Assessment (HTA) Database. Copyright © Canadian Agency for Drugs and Technologies in Health (CADTH). Traducción autorizada.
Revisión sistemática: Dunfield L, Mierzwinski-Urban M. URL del artículo original en inglés disponible en: http://www.cadth.ca/media/pdf/I3006trPalivizumabe.pdf

Los autores del artículo original no se hacen responsables de los posibles errores que hayan podido cometerse en la traducción del mismo.


Structured Abstract Authors

Translated Article

Sorry, there is no English version for this item.

How to cite this article

Aizpurua MP. Profilaxis de la infección por virus respiratorio sincitial con Palivizumab. Traducción autorizada de: Dunfield L, Mierzwinski-Urban M Palivizumab prophylaxis against respiratory syncytial virus. Canadian Agency for Drugs and Technologies in Health (CADTH); 2007; Technology Report No 80. University of York. Centre of Reviews and Dissemination (CRD). Health Technology Assessment (HTA). Database. [Fecha de consulta: 9-5-2007]. Disponible en: http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?View=Full&ID=32007000127. Evid Pediatr. 2007;3:55.

Document Type


01/01/2007

Linked Comment